FFA
NERV icon

Farther Finance Advisors’s Minerva Neurosciences NERV Stock Holding History

Farther Finance Advisors’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555 Hold
100
– – ﹤0.01% 5514
2026
Q1 		$560 Hold
100
– – ﹤0.01% 5246
2025
Q4 		$402 Hold
100
– – ﹤0.01% 5095
2025
Q3 		$211 Hold
100
– – ﹤0.01% 4708
2025
Q2 		$172 Hold
100
– – ﹤0.01% 4231
2025
Q1 		$155 Buy
+100
New +$197 ﹤0.01% 3999

Other funds holding NERV

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Farther Finance Advisors's NERV Position: Q2 2026 in Review

Farther Finance Advisors held its Minerva Neurosciences (NERV) position steady in Q2 2026 at 100 shares worth $555. The position accounts for ﹤0.01% of the portfolio, ranked #5514.

Farther Finance Advisors first reported a position in NERV in Q1 2025 and has held it in 6 quarters since. The position peaked at $560 in Q1 2026. 11 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Farther Finance Advisors held 100 shares of Minerva Neurosciences worth $555 as of Q2 2026.
  • Farther Finance Advisors left its Minerva Neurosciences share count unchanged in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5514 holding.
  • Farther Finance Advisors first reported a position in Minerva Neurosciences in Q1 2025 and has held it in 6 quarters since.
  • Farther Finance Advisors's Minerva Neurosciences position peaked at $560 in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.